{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:52:51Z","timestamp":1792090371329,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40261-021-01001-0","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T21:59:56Z","timestamp":1612907996000},"page":"221-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19"],"prefix":"10.1007","volume":"41","author":[{"name":"AP-HP\/Universities\/INSERM COVID-19 Research Collaboration and AP-HP COVID CDR Initiative","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Hoertel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-8641","authenticated-orcid":false,"given":"Marina","family":"S\u00e1nchez-Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Vernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Jannot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Neuraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Lemogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Airagnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gramfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lemaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lodie","family":"Bernaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bellamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathana\u00ebl","family":"Beeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Limosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"1001_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/s41591-020-1001-6","volume":"26","author":"N Hoertel","year":"2020","unstructured":"Hoertel N, Blachier M, Blanco C, Olfson M, Massetti M, Sanchez-Rico M, et al. A stochastic agent-based model of the SARS-CoV-2 epidemic in France. Nat Med. 2020;26:1417\u201321.","journal-title":"Nat Med"},{"key":"1001_CR2","doi-asserted-by":"publisher","unstructured":"Hoertel N, Blachier M, Blanco C, Olfson M, Massetti M, Limosin F, et al. Facing the COVID-19 epidemic in NYC: a stochastic agent-based model of various intervention strategies. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.04.23.20076885.","DOI":"10.1101\/2020.04.23.20076885"},{"issue":"19","key":"1001_CR3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"J Beigel","year":"2020","unstructured":"Beigel J, Tomashek K, Dodd L, et al. Remdesivir for the treatment of Covid-19\u2014final report. N Engl J Med. 2020;383(19):1813\u201326.","journal-title":"N Engl J Med."},{"key":"1001_CR4","first-page":"m4057","volume":"371","author":"O Dyer","year":"2020","unstructured":"Dyer O. Covid-19: Remdesivir has little or no impact on survival. WHO trial shows BMJ. 2020;371:m4057.","journal-title":"WHO trial shows. BMJ."},{"key":"1001_CR5","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","volume":"383","author":"RECOVERY Collaborative Group","year":"2020","unstructured":"RECOVERY Collaborative Group. Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;383:2030\u201340.","journal-title":"N Engl J Med"},{"key":"1001_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0140-6736(20)30567-5","volume":"395","author":"RM Anderson","year":"2020","unstructured":"Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395:931\u20134.","journal-title":"Lancet"},{"key":"1001_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459\u201368.","journal-title":"Nature"},{"key":"1001_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.encep.2020.04.005","volume":"46","author":"A Chevance","year":"2020","unstructured":"Chevance A, Gourion D, Hoertel N, Llorca P-M, Thomas P, Bocher R, et al. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review. L\u2019Encephale. 2020;46:193\u2013201.","journal-title":"L\u2019Encephale."},{"issue":"21","key":"1001_CR9","first-page":"112","volume":"110","author":"J Delay","year":"1952","unstructured":"Delay J, Deniker P, Harl J. Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP). Ann Med Psychol (Paris). 1952;110(21):112\u20137.","journal-title":"Ann Med Psychol (Paris)."},{"issue":"3","key":"1001_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","volume":"46","author":"M Plaze","year":"2020","unstructured":"Plaze M, Attali D, Petit A, Blatzer M, Simon-Loriere E, Vinckier F, et al. Repurposing chlorpromazine to treat COVID-19: the reCoVery study. Encephale. 2020;46(3):169\u201372.","journal-title":"Encephale."},{"key":"1001_CR11","first-page":"4875","volume":"58","author":"AH De Wilde","year":"2014","unstructured":"De Wilde AH, Jochmans D, Posthuma CC, Zevenhoven-Dobbe JC, Van Nieuwkoop S, Bestebroer TM, et al. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrobial agents and chemotherapy. Am Soc Microbiol. 2014;58:4875\u201384.","journal-title":"Am Soc Microbiol"},{"key":"1001_CR12","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","volume":"58","author":"J Dyall","year":"2014","unstructured":"Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014;58:4885\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"1001_CR13","doi-asserted-by":"publisher","first-page":"e0194868","DOI":"10.1371\/journal.pone.0194868","volume":"13","author":"Y Cong","year":"2018","unstructured":"Cong Y, Gross R, Zhou H, Frieman M, Bollinger L, Wada J, et al. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PLoS ONE. 2018;13:e0194868.","journal-title":"PLoS ONE"},{"key":"1001_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/tra.12272","volume":"16","author":"JA Daniel","year":"2015","unstructured":"Daniel JA, Chau N, Abdel-Hamid MK, Hu L, von Kleist L, Whiting A, et al. Phenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis. Traffic. 2015;16:635\u201354.","journal-title":"Traffic."},{"key":"1001_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","volume":"123","author":"L-H Wang","year":"1993","unstructured":"Wang L-H, Rothberg KG, Anderson R. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol. 1993;123:1107\u201317.","journal-title":"J Cell Biol."},{"key":"1001_CR16","first-page":"217","volume":"79","author":"R Bertini","year":"1993","unstructured":"Bertini R, Garattini S, Delgado R, Ghezzi P. Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology. 1993;79:217.","journal-title":"Immunology"},{"key":"1001_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.173.6.1305","volume":"173","author":"M Gadina","year":"1991","unstructured":"Gadina M, Bertini R, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med. 1991;173:1305\u201310.","journal-title":"J Exp Med"},{"key":"1001_CR18","first-page":"207","volume":"82","author":"M Mengozzi","year":"1994","unstructured":"Mengozzi M, Fantuzzi G, Faggioni R, Marchant A, Goldman M, Orencole S, et al. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice. Immunology. 1994;82:207.","journal-title":"Immunology"},{"key":"1001_CR19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.154.2.861","volume":"154","author":"R Tarazona","year":"1995","unstructured":"Tarazona R, Gonzalez-Garcia A, Zamzami N, Marchetti P, Frechin N, Gonzalo JA, et al. Chlorpromazine amplifies macrophage-dependent IL-10 production in vivo. J Immunol. 1995;154:861\u201370.","journal-title":"J Immunol"},{"key":"1001_CR20","volume-title":"Chlorpromazine","author":"SK Mann","year":"2019","unstructured":"Mann SK, Marwaha R. Chlorpromazine. Treasure Island: StatPearls Publishing; 2019."},{"key":"1001_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.06.20092999","author":"E Williamson","year":"2020","unstructured":"Williamson E, Walker AJ, Bhaskaran KJ, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.06.20092999.","journal-title":"medRxiv."},{"issue":"10229","key":"1001_CR22","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"1001_CR23","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846\u20138.","journal-title":"Intensive Care Med."},{"issue":"6500","key":"1001_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"369","author":"H Salje","year":"2020","unstructured":"Salje H, Kiem CT, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369(6500):208\u201311.","journal-title":"Science"},{"issue":"1","key":"1001_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/0194599820929640","volume":"163","author":"K Hur","year":"2020","unstructured":"Hur K, Price CP, Gray EL, Gulati RK, Maksimoski M, Racette SD, et al. Factors associated with intubation and prolonged intubation in hospitalized patients with COVID-19. Otolaryngol Head Neck Surg. 2020;163(1):170\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1001_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.18332\/tid\/119324","volume":"18","author":"CI Vardavas","year":"2020","unstructured":"Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18:20.","journal-title":"Tob Induc Dis."},{"issue":"5","key":"1001_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/oby.22808","volume":"28","author":"DH Ryan","year":"2020","unstructured":"Ryan DH, Ravussin E, Heymsfield S. COVID 19 and the patient with obesity\u2013the editors speak out. Obesity (Silver Spring). 2020;28(5):847.","journal-title":"Obesity (Silver Spring)."},{"key":"1001_CR28","unstructured":"Haut Conseil de la Sant\u00e9 Publique. Statement on the management at home or in a care facility of suspected or confirmed Covid-19 patients. 2020. https:\/\/www.hcsp.fr."},{"issue":"10","key":"1001_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020;92(10):1733\u20134.","journal-title":"J Med Virol"},{"key":"1001_CR30","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2020.151","author":"R Govind","year":"2020","unstructured":"Govind R, de Freitas DF, Pritchard M, Hayes RD, MacCabe JH. Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. Br J Psychiatry. 2020. https:\/\/doi.org\/10.1192\/bjp.2020.151.","journal-title":"Br J Psychiatry."},{"key":"1001_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.23.20218172","author":"N Hoertel","year":"2020","unstructured":"Hoertel N, S\u00e1nchez M, Vernet R, Beeker N, Neuraz A, Alvarado J, et al. Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: a multicenter retrospective observational study. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.10.23.20218172.","journal-title":"medRxiv."},{"key":"1001_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.09.20143339","author":"N Hoertel","year":"2020","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between SSRI antidepressant use and reduced risk of intubation or death in hospitalized patients with coronavirus disease 2019: a multicenter retrospective observational study. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.07.09.20143339.","journal-title":"medRxiv."},{"key":"1001_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.15.20150490","author":"N Hoertel","year":"2020","unstructured":"Hoertel N, Rico MS, Vernet R, Jannot A-S, Neuraz A, Blanco C, et al. Observational study of haloperidol in hospitalized patients with Covid-19. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.07.15.20150490.","journal-title":"medRxiv"},{"key":"1001_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.23.20154302","author":"N Hoertel","year":"2020","unstructured":"Hoertel N, S\u00e1nchez M, Vernet R, Beeker N, Neuraz A, Blanco C, et al. Association between hydroxyzine use and reduced mortality in patients hospitalized for coronavirus disease 2019: results from a multicenter observational study. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.10.23.20154302.","journal-title":"medRxiv"},{"key":"1001_CR35","unstructured":"Devlin J, Chang M-W, Lee K, Toutanova K. Bert: Pre-training of deep bidirectional transformers for language understanding. 2018. arXiv:1810.04805v2."},{"key":"1001_CR36","doi-asserted-by":"crossref","unstructured":"Jouffroy J, Feldman SF, Lerner I, Rance B, Neuraz A, Burgun A. MedExt: combining expert knowledge and deep learning for medication extraction from French clinical texts. ResearchGate. 2020;\u00a0preprint.\u00a0https:\/\/www.researchgate.net\/publication\/339156636. Accessed 26 Jan 2021.","DOI":"10.2196\/preprints.17934"},{"key":"1001_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the cox model. New York: Springer; 2000."},{"key":"1001_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v084.i02","volume":"84","author":"D Dunkler","year":"2018","unstructured":"Dunkler D, Ploner M, Schemper M, Heinze G. Weighted cox regression using the R Package coxphw. J Stat Softw. 2018;84:1\u201326.","journal-title":"J Stat Softw"},{"key":"1001_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hern\u00e1n M\u00c1, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550\u201360.","journal-title":"Epidemiology."},{"key":"1001_CR40","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382:2411\u20138.","journal-title":"N Engl J Med."},{"key":"1001_CR41","unstructured":"Kassambara A, Kosinski M, Biecek P. survminer: Drawing Survival Curves using \u201cggplot2\u201d. 2020. https:\/\/CRAN.R-project.org\/package=survminer."},{"key":"1001_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc."},{"key":"1001_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2307\/3314608","volume":"9","author":"B Efron","year":"1981","unstructured":"Efron B. Nonparametric standard errors and confidence intervals. Can J Stat. 1981;9:139\u201358.","journal-title":"Can J Stat."},{"key":"1001_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1198\/106186006X137047","volume":"15","author":"BB Hansen","year":"2006","unstructured":"Hansen BB, Klopfer SO. Optimal full matching and related designs via network flows. J Comput Graph Stat. 2006;15:609\u201327.","journal-title":"J Comput Graph Stat."},{"key":"1001_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573\u20137.","journal-title":"Ann Intern Med"},{"key":"1001_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-020-02346-9","author":"H Javelot","year":"2020","unstructured":"Javelot H, Weiner L, Petrignet J, Meyer G, Briet J, El-Hage W, et al. Psychoactive compounds as multifactorial protection factors against COVID-19. Ir J Med Sci. 2020. https:\/\/doi.org\/10.1007\/s11845-020-02346-9.","journal-title":"Ir J Med Sci."},{"key":"1001_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00880-7","author":"QQ Wang","year":"2020","unstructured":"Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2020. https:\/\/doi.org\/10.1038\/s41380-020-00880-7.","journal-title":"Mol Psychiatry."},{"key":"1001_CR48","doi-asserted-by":"publisher","first-page":"e2023282","DOI":"10.1001\/jamanetworkopen.2020.23282","volume":"3","author":"L Li","year":"2020","unstructured":"Li L, Li F, Fortunati F, Krystal JH. Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) infection. JAMA Netw Open. 2020;3:e2023282.","journal-title":"JAMA Netw Open."},{"key":"1001_CR49","doi-asserted-by":"publisher","first-page":"106129","DOI":"10.1016\/j.ijantimicag.2020.106129","volume":"56","author":"B Davido","year":"2020","unstructured":"Davido B, Boussaid G, Vaugier I, Lansaman T, Bouchand F, Lawrence C, et al. Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time. Int J Antimicrob Agents. 2020;56:106129.","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-021-01001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-021-01001-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-021-01001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T18:09:08Z","timestamp":1697825348000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-021-01001-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1007\/s40261-021-01001-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.15.20154310","asserted-by":"object"}]},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"assertion":[{"value":"15 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work did not receive any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Nicolas Hoertel has received personal fees and non-financial support from Lundbeck, outside the submitted work; C\u00e9dric Lemogne reports personal fees and non-financial support from Janssen-Cilag, Lundbeck, Otsuka Pharmaceutical, and Boehringer Ingelheim, outside the submitted work; Guillaume Airagnes reports personal fees from Pfizer, Pierre Fabre and Lundbeck, outside the submitted work; and Fr\u00e9d\u00e9ric Limosin has received speaker and consulting fees from Janssen-Cilag outside the submitted work. Marina Sanchez-Rico, Rapha\u00ebl Vernet, Anne-Sophie Jannot, Antoine Neuraz, Carlos Blanco, Nicolas Paris, Christel Daniel, Alexandre Gramfort, Guillaume Lemaitre, M\u00e9lodie Bernaux, Ali Bellamine, and Nathana\u00ebl Beeker declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures related to this work adhered to the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. This study received approval from the Institutional Review Board of the AP-HP Clinical Data Warehouse (decision CSE-20-20_COVID19, IRB00011591).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The AP-HP Clinical Data Warehouse initiative ensures patient information and consent regarding the different approved studies through a transparency portal in accordance with the European Regulation on Data Protection and Authorization number 1980120 from the National Commission for Information Technology and Civil Liberties (CNIL). Participants who did not consent to participate in this study were excluded.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data from the AP-HP Health Data Warehouse can be obtained with permission at\n                      \n                      \/.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"NH designed the study, performed statistical analyses, and wrote the first draft of the manuscript. MSR performed statistical analyses and critically revised the manuscript. RV contributed to the statistical analyses and critically revised the manuscript for scientific content. FL, NB, and ASJ contributed to the study design and critically revised the manuscript for scientific content. NB, ASJ, AN, NP, CD, AG, GL, MB, and AB contributed to the database build process. All authors critically revised the manuscript for scientific content.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}